Long-Term Changes in Gut Microbial Metabolite Trimethylamine N-Oxide and Coronary Heart Disease Risk
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Background: A gut-microbial metabolite, trimethylamine N-oxide (TMAO) has been associated with coronary atherosclerotic burden. No previous prospective study has addressed associations of long-term changes in TMAO with coronary heart disease (CHD) incidence. Objective: To investigate whether 10-year changes in plasma TMAO levels were significantly associated with CHD incidence. Methods: This prospective nested case-control study included 760 healthy women at baseline. Plasma TMAO levels were measured both at the first (1989–90) and the second blood collections (2000–02); 10-year changes (Δ) in TMAO were calculated. Incident cases of CHD (n=380) were identified after the second blood collection through 2016 and were matched to controls (n=380). Results: Regardless of the initial TMAO levels, 10-year increases in TMAO from the first to second blood collections were significantly associated with an increased risk of CHD (relative risk [RR] in the top tertile: 1.58 [95% CI: 1.05, 2.38]; RR per 1 SD increment: 1.33 [1.06, 1.67]). Participants with elevated TMAO levels (the top tertile) at both time points showed the highest RR of 1.79 (1.08, 2.96) for CHD as compared with those with consistently low TMAO levels. Further, we found that the ΔTMAO-CHD relationship was strengthened by unhealthy dietary patterns (assessed by the Alternate Healthy Eating Index) and was attenuated by healthy dietary patterns (Pinteraction=0.008). Conclusions: Long-term increases in TMAO were associated with higher CHD risk, and repeated assessment of TMAO over 10 years improved the identification of people with a higher risk of CHD. Diet may modify the associations of ΔTMAO with CHD risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597 · cited 3×
“Blood concentrations of TMAO at the first and second blood collections were measured at the Cleveland Clinic using an established stable isotope dilution highperformance liquid chromatography with electrospray ionization tandem mass spectrometry (2,3).”
BackgroundMethodSelf-citationIntestinal microbial metabolism of phosphatidylcholine and cardiovascular risk
Tang, W. H. W., Wang, Z., Levison, B. S., Koeth, R. A., Britt, E. B., Fu, X., Wu, Y., & Hazen, S. L. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1109400 · Cited by 3,400
Role of the gut microbiota in nutrition and health
Valdes, A. M., Walter, J., Segal, E., & Spector, T. D. (2018) · BMJ · doi:10.1136/bmj.k2179 · Cited by 2,375
Alternative Dietary Indices Both Strongly Predict Risk of Chronic Disease
Chiuve, S. E., Fung, T. T., Rimm, E. B., Hu, F. B., McCullough, M. L., Wang, M., Stampfer, M. J., & Willett, W. C. (2012) · The Journal of Nutrition · doi:10.3945/jn.111.157222 · Cited by 1,951
Self-citationThe gut microbiome in atherosclerotic cardiovascular disease
Jie, Z., Xia, H., Zhong, S.-L., Feng, Q., Li, S., Liang, S., Zhong, H., Liu, Z., Gao, Y., Zhao, H., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00900-1 · Cited by 1,638 · cited 3×
“Growing evidence has implicated gut microbiota alterations in the development of atherosclerotic cardiovascular disease (CVD) (1).”
BackgroundWang, Z., Roberts, A. B., Buffa, J. A., Levison, B. S., Zhu, W., Org, E., Gu, X., Huang, Y., Zamanian-Daryoush, M., Culley, M. K., et al. (2015) · Cell · doi:10.1016/j.cell.2015.11.055 · Cited by 1,317 · cited 1×
“A study reported that a nonlethal inhibitor that blocks the production of TMA (which in turn reduces the production of TMAO) from choline might prevent the formation of atherosclerotic lesions (23), suggesting a potential role of the gut microbial TMA lyases as a therapeutic target for atherosclerosis.”
BackgroundSelf-citationBennett, B. J., Vallim, T. Q. D. A., Wang, Z., Shih, D. M., Meng, Y., Gregory, J., Allayee, H., Lee, R., Graham, M., Crooke, R., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2012.12.011 · Cited by 1,070 · cited 1×
“The intestinal microbiota metabolizes nutrient precursors of TMAO, such as choline and Lcarnitine that are abundant in animal foods, to produce trimethylamine (TMA) (2,10), which is further metabolized to TMAO by the flavin-containing enzyme monooxygenase 3 (FMO3) in the liver (11,12).”
BackgroundThe gut microbiota at the intersection of diet and human health
Gentile, C. L., & Weir, T. L. (2018) · Science · doi:10.1126/science.aau5812 · Cited by 1,049
Validity of Self-Reported Waist and Hip Circumferences in Men and Women
Rimm, E. B., Stampfer, M. J., Colditz, G. A., Chute, C. G., Litin, L. B., & Willett, W. C. (1990) · Epidemiology · doi:10.1097/00001648-199011000-00009 · Cited by 1,015
Self-citationCOLDITZ, G. A., MARTIN, P., STAMPFER, M. J., WILLETT, W. C., SAMPSON, L., ROSNER, B., HENNEKENS, C. H., & SPEIZER, F. E. (1986) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114319 · Cited by 992 · cited 1×
“Previous studies have confirmed the validity of self-reported histories of physiciandiagnosed hypertension, high cholesterol, and diabetes (32,33); use of medication for the respective disease (such as antihypertensive medications, statin or other cholesterol-lowering medications, and insulin or oral hypoglycemic medi…”
ResultHealthful and Unhealthful Plant-Based Diets and the Risk of Coronary Heart Disease in U.S. Adults
Satija, A., Bhupathiraju, S. N., Spiegelman, D., Chiuve, S. E., Manson, J. E., Willett, W., Rexrode, K. M., Rimm, E. B., & Hu, F. B. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.05.047 · Cited by 991 · cited 2×
“As described previously (34,35), we calculated the Alternate Healthy Eating Index (AHEI) (34) and the healthful plant-based diet index in which healthy plant foods received positive scores, and the other foods received negative scores (35) (Supplemental Appendix).”
BackgroundMethodSelf-citationSeldin, M. M., Meng, Y., Qi, H., Zhu, W., Wang, Z., Hazen, S. L., Lusis, A. J., & Shih, D. M. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002767 · Cited by 911
Schiattarella, G. G., Sannino, A., Toscano, E., Giugliano, G., Gargiulo, G., Franzone, A., Trimarco, B., Esposito, G., & Perrino, C. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx342 · Cited by 563
Development of a gut microbe–targeted nonlethal therapeutic to inhibit thrombosis potential
Roberts, A. B., Gu, X., Buffa, J. A., Hurd, A. G., Wang, Z., Zhu, W., Gupta, N., Skye, S. M., Cody, D. B., Levison, B. S., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0128-1 · Cited by 552
Self-citationHeianza, Y., Ma, W., Manson, J. E., Rexrode, K. M., & Qi, L. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.004947 · Cited by 544
Self-citationWang, Z., Bergeron, N., Levison, B. S., Li, X. S., Chiu, S., Jia, X., Koeth, R. A., Li, L., Wu, Y., Tang, W. H. W., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehy799 · Cited by 496 · cited 3×
“A more recent study reported similar associations that intake of red meat increased TMAO levels, and discontinuation of red meat intake reduced plasma TMAO levels within 4 weeks (29).”
BackgroundAssociation of changes in diet quality with total and cause-specific mortality
Sotos-Prieto, M., Bhupathiraju, S. N., Mattei, J., Fung, T. T., Li, Y., Pan, A., Willett, W. C., Rimm, E. B., & Hu, F. B. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1613502 · Cited by 466 · cited 2×
“The AHEI and the healthful plant-based diet index are predictive of chronic diseases and cardiovascular mortality risks in the NHS cohort (21,34,35).”
BackgroundSerum Trimethylamine-N-Oxide is Elevated in CKD and Correlates with Coronary Atherosclerosis Burden
Stubbs, J. R., House, J. A., Ocque, A. J., Zhang, S., Johnson, C., Kimber, C., Schmidt, K., Gupta, A., Wetmore, J. B., Nolin, T. D., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014111063 · Cited by 450
The TMAO-Generating Enzyme Flavin Monooxygenase 3 Is a Central Regulator of Cholesterol Balance
Warrier, M., Shih, D. M., Burrows, A. C., Ferguson, D., Gromovsky, A. D., Brown, A. L., Marshall, S., McDaniel, A., Schugar, R. C., Wang, Z., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2014.12.036 · Cited by 414 · cited 1×
“Our observations are supported by previous findings from experimental studies such as that modulation of the TMAO-generating enzyme FMO3 impacts systemic TMAO levels (38), and the FMO3 is involved in atherosclerotic pathogenesis by regulating cholesterol metabolism and insulin resistance (39,40).”
ResultFlavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosis
Miao, J., Ling, A. V., Manthena, P. V., Gearing, M. E., Graham, M. J., Crooke, R. M., Croce, K. J., Esquejo, R. M., Clish, C. B., Morbid Obesity Study Group, et al. (2015) · Nature Communications · doi:10.1038/ncomms7498 · Cited by 368 · cited 1×
“Our observations are supported by previous findings from experimental studies such as that modulation of the TMAO-generating enzyme FMO3 impacts systemic TMAO levels (38), and the FMO3 is involved in atherosclerotic pathogenesis by regulating cholesterol metabolism and insulin resistance (39,40).”
Resultl-Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans
Koeth, R. A., Lam-Galvez, B. R., Kirsop, J., Wang, Z., Levison, B. S., Gu, X., Copeland, M. F., Bartlett, D., Cody, D. B., Dai, H. J., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci94601 · Cited by 327
Self-citationRelationship of Serum Trimethylamine N-Oxide (TMAO) Levels with early Atherosclerosis in Humans
Randrianarisoa, E., Lehn-Stefan, A., Wang, X., Hoene, M., Peter, A., Heinzmann, S. S., Zhao, X., Königsrainer, I., Königsrainer, A., Balletshofer, B., et al. (2016) · Scientific Reports · doi:10.1038/srep26745 · Cited by 296
Ke, Y., Li, D., Zhao, M., Liu, C., Liu, J., Zeng, A., Shi, X., Cheng, S., Pan, B., Zheng, L., et al. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.01.007 · Cited by 285
Gut Microbe-Generated Trimethylamine N -Oxide From Dietary Choline Is Prothrombotic in Subjects
Zhu, W., Wang, Z., Tang, W. H. W., & Hazen, S. L. (2017) · Circulation · doi:10.1161/circulationaha.116.025338 · Cited by 274 · cited 1×
“One study suggested that increases in TMAO induced by dietary choline intake were associated with an enhanced prothrombotic effect in human subjects (22).”
BackgroundHeianza, Y., Sun, D., Li, X., DiDonato, J. A., Bray, G. A., Sacks, F. M., & Qi, L. (2019) · Gut · doi:10.1136/gutjnl-2018-316155 · Cited by 177
Self-citationZhu, W., Buffa, J. A., Wang, Z., Warrier, M., Schugar, R., Shih, D. M., Gupta, N., Gregory, J. C., Org, E., Fu, X., et al. (2018) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14234 · Cited by 161
Self-citationKe, Y., Li, D., Zhao, M., Liu, C., Liu, J., Zeng, A., Shi, X., Cheng, S., Pan, B., Zheng, L., et al. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.06.007 · Cited by 17
Cited by
Systems biology in cardiovascular disease: a multiomics approach
Joshi, A., Rienks, M., Theofilatos, K., & Mayr, M. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00477-1 · Cited by 301
Li, J., Li, Y., Ivey, K. L., Wang, D. D., Wilkinson, J. E., Franke, A., Lee, K. H., Chan, A., Huttenhower, C., Hu, F. B., et al. (2022) · Gut · doi:10.1136/gutjnl-2020-322473 · Cited by 137
Self-citationFrom taxonomy to metabolic output: what factors define gut microbiome health?
Wilmanski, T., Rappaport, N., Diener, C., Gibbons, S. M., & Price, N. D. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1907270 · Cited by 73
“TMAO has been shown to promote cardiovascular disease in animal models,(122) and is associated with increased risk of cardiovascular disease in humans.(123,124) The histidine microbial catabolite imidazole propionate was recently shown to be more readily synthesized by gut microbiomes of type II diabetic patients rela…”
Background
Metadata
- Authors
- Heianza, Y., Ma, W., DiDonato, J. A., Sun, Q., Rimm, E. B., Hu, F. B., Rexrode, K. M., Manson, J. E., & Qi, L.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2020-02
- Volume
- 75
- Issue
- 7
- Pages
- 763-772
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W3006191960
- Cited by
- 158
- References
- 27
- FWCI
- 5.74
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.